KDM4-INHIBITOREN

Patent europeic · EP3600301 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3600301
Numer da la dumonda
EP18774276
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
27-03-2018
Publitgà
05-02-2020
Concedì
03-07-2024
Stritgà
23-10-2025
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 213/79 (2006.01)
A61K 31/44 (2006.01)
A61P 25/00 (2006.01)
Prioritad
US 201762478785 P 30.03.2017
US 201762513875 P 01.06.2017
Dumonda PCT
PCT/US2018/024624 27.03.2018
Publicaziun PCT
WO2018/183370 04.10.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-10-2025

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.10.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.10.2025

  2. 14-05-2025

    Midada

    Published in Swissreg on 14.05.2025

  3. 03-07-2024

    Concedì

    Published in Swissreg on 03.07.2024

Partidas

Possessur

Celgene Quanticel Research, Inc.

9393 Towne Centre Drive, Suite 110, San Diego, CA 92121, US

Albert-Ludwigs-Universität Freiburg

Zentrale Klinische Forschung Breisacher Str. 66, 79106 Freiburg, DE

Inventur

METZGER, Eric

79106 Freiburg, DE

SCHÜLE, Roland

79106 Freiburg, DE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.